POLQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.649000E-01
Normal-vs-Stage2
8.682400E-01
Normal-vs-Stage3
5.431800E-01
Normal-vs-Stage4
9.820600E-01
Stage1-vs-Stage2
5.480800E-01
Stage1-vs-Stage3
5.558000E-01
Stage1-vs-Stage4
8.615200E-01
Stage2-vs-Stage3
2.059200E-01
Stage2-vs-Stage4
8.120800E-01
Stage3-vs-Stage4
4.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.390200E-01
Normal-vs-AfricanAmerican
9.277200E-01
Normal-vs-Asian
9.097600E-01
Caucasian-vs-AfricanAmerican
9.302000E-01
Caucasian-vs-Asian
9.405000E-01
AfricanAmerican-vs-Asian
9.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.736800E-01
Normal-vs-Female
7.901200E-01
Male-vs-Female
9.150400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.591200E-01
Normal-vs-Age(41-60Yrs)
8.199200E-01
Normal-vs-Age(61-80Yrs)
9.872200E-01
Normal-vs-Age(81-100Yrs)
8.216000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.661970E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.908190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.795230E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.397000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.555000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.697400E-01
Normal-vs-Daily Drinker
9.116200E-01
Normal-vs-Weekly Drinker
8.356400E-01
Normal-vs-Occasional Drinker
7.186000E-01
Normal-vs-Social Drinker
8.426600E-01
Non Drinker-vs-Daily Drinker
7.460600E-01
Non Drinker-vs-Weekly Drinker
6.458000E-01
Non Drinker-vs-Occasional Drinker
4.337400E-01
Non Drinker-vs-Social Drinker
6.532200E-01
Daily Drinker-vs-Weekly Drinker
8.604600E-01
Daily Drinker-vs-Occasional Drinker
6.382000E-01
Daily Drinker-vs-Social Drinker
8.754000E-01
Weekly Drinker-vs-Occasional Drinker
7.918800E-01
Weekly Drinker-vs-Social Drinker
9.820200E-01
Occasional Drinker-vs-Social Drinker
7.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.282200E-01
Normal-vs-Grade 2
7.981200E-01
Normal-vs-Grade 3
6.909000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.07380000000401E-05
Grade 1-vs-Grade 3
2.38059999999596E-05
Grade 1-vs-Grade 4
6.282200E-01
Grade 2-vs-Grade 3
1.655200E-01
Grade 2-vs-Grade 4
7.981200E-01
Grade 3-vs-Grade 4
6.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.349400E-01
Normal-vs-NonDiabetic
8.971800E-01
Diabetic-vs-NonDiabetic
3.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.132600E-01
Normal-vs-NoPancreatitis
9.816400E-01
Pancreatitis-vs-NoPancreatitis
9.831800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.772000E-01
Normal-vs-N1
8.903800E-01
N0-vs-N1
5.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.547000E-01
Normal-vs-TP53-NonMutant
8.959400E-01
TP53-Mutant-vs-TP53-NonMutant
2.22000000005274E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
